Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT06941103
Starting soon Not applicable

Spinal Stabilization Exercise Training in Women With Chronic Constipation

NCT06941103 · tracked via the Priya Life Science Turkey tracker
Sponsor
Özel Artı Disleksi Özel Eğitim ve Rehabilitasyon Merkezi
Phase
Not applicable
Started
2025-05-25
Last updated
2025-04-23

Condition(s) studied

Constipation

Investigational drug(s) / intervention(s)

Spinal stabilization exercise training and recommendationRecommendation

Spinal stabilization exercise training and recommendation: Spinal stabilization exercise training will be applied 3 days a week for 8 weeks under the supervision of a specialist physiotherapist. Exercises consist of a 5-10 minute warm-up period, 40 minutes SSET and a 5-10 minute cool-down period. Within the scope of the recommendation, information will be given about the definition of constipation, risk factors, and treatment methods.. A brochure will be prepared to be distributed to individuals regarding these issues.

Recommendation: Within the scope of the recommendation, information will be given about the definition of constipation, risk factors, and treatment methods.. A brochure will be prepared to be distributed to individuals regarding these issues.

Study summary

This study was planned to investigate the effects of spinal stabilization exercise training on constipation symptom severity, quality of life, perception of recovery, and spinal stability in women with chronic constipation.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with chronic functional constipation according to Rome 4 diagnostic criteria * Those between the ages of 18-65 * Women who volunteer to participate in the study will be included. Exclusion Criteria: * Those who are pregnant or breastfeeding * Neurological diseases (Parkinson, Multiple Sclerosis, hemiplegia, etc.) * Undercontrolled systemic/metabolic diseases (hypothyroidism, diabetes mellitus, hypokalemia, hypercalcemia, hypomagnesemia, etc.) * Malignant diseases * Accompanying colon or gastrointestinal problems (gastrointestinal bleeding, acute inflammation, etc.) * Secondary constipation presence of alarm symptoms (new onset constipation, rectal bleeding, involuntary weight loss, nausea, vomiting, fever, anemia or a family history of gastrointestinal malignancy) * Those who received treatment (exercise, surgery, etc.) for the abdominolumbopelvic region in the last year * Having a history of colostomy or colectomy * Those with orthopedic limitations that would affect spinal stabilization exercise training * Those who do not participate in the treatment program regularly.

Primary outcome measure(s)

  • Constipation Severity Scale (CSI) — two weeks
    Scale Varma et al. it was developed by to determine individuals' defecation frequency, intensity and difficulty experienced during defecation. Kaya et al. Turkish validity and reliability were conducted by . The scale consists of 16 questions and three sub-areas. These areas are 1. Fecal Obstruction, 2. Large Intestinal Laziness and 3. Pain. The lowest total score that can be obtained from the scale is 0 and the highest is 73. A high score indicates that the symptoms are serious.

Trial sites (1)

FacilityCityRegionStatus
Özel Artı Disleksi Özel Eğitim ve Rehabilitasyon Merkezi Ankara Turkey (Türkiye)

Other trials for the same condition

Effect of Abdominal Massage Training Provided to Caregivers on Constipation Management Recruiting
Constipation in Children With Cerebral Palsy Active, not recruiting
Measurement of Ultrasonographic Rectal Diameter in Children With Constipation Active, not recruiting
Relationship Between Interoception and Postural Control in Constipation-Predominant Irritable Bowel Syndrome Recruiting
GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06941103 on ClinicalTrials.gov ↗ ← All trials in Turkey